0001144204-14-030644.txt : 20140515 0001144204-14-030644.hdr.sgml : 20140515 20140514190936 ACCESSION NUMBER: 0001144204-14-030644 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140331 FILED AS OF DATE: 20140515 DATE AS OF CHANGE: 20140514 EFFECTIVENESS DATE: 20140515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management I, LLC CENTRAL INDEX KEY: 0001581219 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15934 FILM NUMBER: 14843260 BUSINESS ADDRESS: STREET 1: 101 CALIFORNIA STREET, SUITE 4100 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 101 CALIFORNIA STREET, SUITE 4100 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001581219 XXXXXXXX 03-31-2014 03-31-2014 false Foresite Capital Management I, LLC

101 California Street, Suite 4100 San Francisco CA 94111

13F HOLDINGS REPORT 028-15934 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 05-14-2014 0 11 142352 INFORMATION TABLE 2 infotable.xml Acceleron Pharma Inc. COM 00434H108 721 20892 SH SOLE 20892 0 0 ACELRX Pharmaceuticals, Inc. COM 00444T100 16563 1379080 SH SOLE 1379080 0 0 Ambit Biosciences Corporation COM 02318X100 18966 2079569 SH SOLE 2079569 0 0 BioDelivery Sciences International, Inc. COM 09060J106 5908 700000 SH SOLE 700000 0 0 Ignyta, Inc. COM 451731103 4150 500000 SH SOLE 500000 0 0 Karyopharm Therapeutics Inc. COM 48576U106 48984 1585743 SH SOLE 1585743 0 0 Keryx Biopharmaceuticals Inc. COM 492515101 22357 1312006 SH SOLE 1312006 0 0 Novavax Inc. COM 670002104 6053 1336200 SH SOLE 1336200 0 0 Novavax Inc. COM 670002104 906 2000 SH Put SOLE 2000 0 0 Orexigen Therapeutics, Inc. COM 686164104 8125 1250000 SH SOLE 1250000 0 0 Xencor, Inc. COM 98401F105 9619 820000 SH SOLE 820000 0 0